188 related articles for article (PubMed ID: 17845211)
1. Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophils.
Shpacovitch VM; Seeliger S; Huber-Lang M; Balkow S; Feld M; Hollenberg MD; Sarma VJ; Ward PA; Strey A; Gerke V; Sommerhoff CP; Vergnolle N; Steinhoff M
Exp Dermatol; 2007 Oct; 16(10):799-806. PubMed ID: 17845211
[TBL] [Abstract][Full Text] [Related]
2. Induction of lactoferrin and IL-8 release from human neutrophils by tryptic enzymes via proteinase activated receptor-2.
Wang H; He S
Cell Biol Int; 2006 Sep; 30(9):688-97. PubMed ID: 16820307
[TBL] [Abstract][Full Text] [Related]
3. Agonists of proteinase-activated receptor-2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3-D collagen lattices.
Shpacovitch VM; Varga G; Strey A; Gunzer M; Mooren F; Buddenkotte J; Vergnolle N; Sommerhoff CP; Grabbe S; Gerke V; Homey B; Hollenberg M; Luger TA; Steinhoff M
J Leukoc Biol; 2004 Aug; 76(2):388-98. PubMed ID: 15155775
[TBL] [Abstract][Full Text] [Related]
4. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
5. The antidiabetic agent, gliclazide, reduces high insulin-enhanced neutrophil-transendothelial migration through direct effects on the endothelium.
Okouchi M; Okayama N; Omi H; Imaeda K; Fukutomi T; Nakamura A; Itoh M
Diabetes Metab Res Rev; 2004; 20(3):232-8. PubMed ID: 15133755
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of serine proteases on the migration of normal and tumor cells: implications for tumor microenvironment.
Elzer KL; Heitzman DA; Chernin MI; Novak JF
Integr Cancer Ther; 2008 Dec; 7(4):282-94. PubMed ID: 19116224
[TBL] [Abstract][Full Text] [Related]
7. ANCA induces beta2 integrin and CXC chemokine-dependent neutrophil-endothelial cell interactions that mimic those of highly cytokine-activated endothelium.
Calderwood JW; Williams JM; Morgan MD; Nash GB; Savage CO
J Leukoc Biol; 2005 Jan; 77(1):33-43. PubMed ID: 15459232
[TBL] [Abstract][Full Text] [Related]
8. The role of neutrophils in severe sepsis.
Alves-Filho JC; de Freitas A; Spiller F; Souto FO; Cunha FQ
Shock; 2008 Oct; 30 Suppl 1():3-9. PubMed ID: 18704017
[TBL] [Abstract][Full Text] [Related]
9. Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway.
Khoufache K; LeBouder F; Morello E; Laurent F; Riffault S; Andrade-Gordon P; Boullier S; Rousset P; Vergnolle N; Riteau B
J Immunol; 2009 Jun; 182(12):7795-802. PubMed ID: 19494303
[TBL] [Abstract][Full Text] [Related]
10. Induction of monocyte chemoattractant protein-1 release from A549 cells by agonists of protease-activated receptor-1 and -2.
Wang H; Yi T; Zheng Y; He S
Eur J Cell Biol; 2007 Apr; 86(4):233-42. PubMed ID: 17280738
[TBL] [Abstract][Full Text] [Related]
11. The role of protease-activated receptors PAR-1 and PAR-2 in the repair of 16HBE 14o(-) epithelial cell monolayers in vitro.
Ewen D; Clarke SL; Smith JR; Berger C; Salmon G; Trevethick M; Shute JK
Clin Exp Allergy; 2010 Mar; 40(3):435-49. PubMed ID: 20210813
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis.
Sandberg WJ; Halvorsen B; Yndestad A; Smith C; Otterdal K; Brosstad FR; Frøland SS; Olofsson PS; Damås JK; Gullestad L; Hansson GK; Oie E; Aukrust P
Circ Res; 2009 Jan; 104(1):60-8. PubMed ID: 19023130
[TBL] [Abstract][Full Text] [Related]
13. Neutrophils from MMP-9- or neutrophil elastase-deficient mice show no defect in transendothelial migration under flow in vitro.
Allport JR; Lim YC; Shipley JM; Senior RM; Shapiro SD; Matsuyoshi N; Vestweber D; Luscinskas FW
J Leukoc Biol; 2002 May; 71(5):821-8. PubMed ID: 11994507
[TBL] [Abstract][Full Text] [Related]
14. The effect of anticoagulants and the role of thrombin on neutrophil-endothelial cell interactions in septic shock.
Tsen A; Kirschenbaum LA; LaRow C; Khan R; Kurtz S; Bansal S; Astiz ME
Shock; 2009 Feb; 31(2):120-4. PubMed ID: 18636042
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant activated protein C and low-dose heparin on neutrophil-endothelial cell interactions in septic shock.
Kirschenbaum LA; Lopez WC; Ohrum P; Tsen A; Khazin J; Astiz ME
Crit Care Med; 2006 Aug; 34(8):2207-12. PubMed ID: 16775572
[TBL] [Abstract][Full Text] [Related]
16. Proteinase-activated receptor-2 in the skin: receptor expression, activation and function during health and disease.
Rattenholl A; Steinhoff M
Drug News Perspect; 2008 Sep; 21(7):369-81. PubMed ID: 19259550
[TBL] [Abstract][Full Text] [Related]
17. Hepta and octapeptide agonists of protease-activated receptor 2.
Devlin MG; Pfeiffer B; Flanagan B; Beyer RL; Cocks TM; Fairlie DP
J Pept Sci; 2007 Dec; 13(12):856-61. PubMed ID: 17890655
[TBL] [Abstract][Full Text] [Related]
18. Role of protease-activated receptor-1 in endothelial nitric oxide synthase-Thr495 phosphorylation.
Watts VL; Motley ED
Exp Biol Med (Maywood); 2009 Feb; 234(2):132-9. PubMed ID: 19064940
[TBL] [Abstract][Full Text] [Related]
19. Induction of inflammatory cytokine release from human umbilical vein endothelial cells by agonists of proteinase-activated receptor-2.
Niu QX; Chen HQ; Chen ZY; Fu YL; Lin JL; He SH
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):89-96. PubMed ID: 18047634
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal administration of proteinase-activated receptor-2 agonists produces hyperalgesia by exciting the cell bodies of primary sensory neurons.
Alier KA; Endicott JA; Stemkowski PL; Cenac N; Cellars L; Chapman K; Andrade-Gordon P; Vergnolle N; Smith PA
J Pharmacol Exp Ther; 2008 Jan; 324(1):224-33. PubMed ID: 17921188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
